Publications by authors named "Wilson Miller"

Claim this Profile
R
Reader Comment on: Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian Perspective.
Ghassan Barnawi, Raquel Lazarowitz, Erika Bushatsky Andrade de Alencar, Wilson H Miller, Ivan V Litvinov

J Cutan Med Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.
François Santinon, Theodoros Papadopoulos, Meagan-Helen Henderson Berg, Paige McCallum, Madelyn J Abraham, Wilson H Miller

J Inflamm (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort study.
Rami Habib, Wilson H Miller, Theodore Papadopoulos, Sonia V Del Rincon, Claudie Berger

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for antibody optimization and panel design in high-dimensional multiplexed immunofluorescence imaging.
Vrinda Gupta, Madelyn J Abraham, Christophe Goncalves, Wilson H Miller, Sonia V Del Rincón

STAR Protoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Divarasib in Patients With -Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.
Adrian G Sacher, Wilson H Miller, Manish R Patel, Luis Paz-Ares, Armando Santoro

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused ultrasound-microbubble treatment arrests the growth and formation of cerebral cavernous malformations.
Delaney G Fisher, Tanya Cruz, Matthew R Hoch, Khadijeh A Sharifi, Ishaan M Shah, G Wilson Miller

Nat Biomed Eng· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, Wilson H Miller, Rahima Jamal

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused ultrasound augments the delivery and penetration of model therapeutics into cerebral cavernous malformations.
Delaney G Fisher, Matthew R Hoch, Catherine M Gorick, Claire Huchthausen, Victoria R Breza, G Wilson Miller

J Control Release· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, Marcus O Butler, Matthew H Taylor

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization.
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, Adrienne N Nedved, Justine L Wilson-Miller

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma.
Antoine Méant, Omar Moussa, Benjamin Lebeau, Christophe Gonçalves, Vincent R Richard, Wilson H Miller

J Invest Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization.
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, Adrienne N Nedved, Justine L Wilson-Miller

JCO Oncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.
Diana Berry, Dan Moldoveanu, Shivshankari Rajkumar, Mathieu Lajoie, Tiffany Lin, Wilson H Miller

Cell Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.
Cristiano Ferrario, John Mackey, Karen A Gelmon, Nathalie Levasseur, Poul H Sorensen, Wilson H Miller

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley, Giovani M Bariani, Philippe A Cassier, Aurelien Marabelle, Aaron R Hansen, Wilson H Miller

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial.
Aurelien Marabelle, David M O'Malley, Andrew E Hendifar, Paolo A Ascierto, Daniel Motola-Kuba, Wilson H Miller

Nat Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Ultrasound Augments the Delivery and Penetration of Model Therapeutics into Cerebral Cavernous Malformations.
Delaney G Fisher, Matthew R Hoch, Catherine M Gorick, Claire Huchthausen, Victoria R Breza, G Wilson Miller

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors.
Nehal J Lakhani, Howard Burris, Wilson H Miller, Mo Huang, Lin-Chi Chen

Invest New Drugs· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Incurable Cancer Patients Treated with Unlisted Anticancer Treatments in an Academic Center in Quebec, Canada.
Adam Miller, Francois Panet, Victoria Korsos, Wilson H Miller, Gerald Batist

Curr Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.
Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González, Christophe Gonçalves, Vincent R Richard, Wilson H Miller

Sci Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
Byoung Chul Cho, Irene Braña, Beatriz Cirauqui, Sercan Aksoy, Felix Couture, Wilson H Miller

BMC Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller

Invest New Drugs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E Issa, Wilson H Miller

J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
Yao Zhan, Jun Guo, William Yang, Christophe Goncalves, Tomasz Rzymski, Wilson H Miller

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Ultrasound Blood-Brain Barrier Opening Arrests the Growth and Formation of Cerebral Cavernous Malformations.
Delaney G Fisher, Khadijeh A Sharifi, Ishaan M Shah, Catherine M Gorick, Victoria R Breza, G Wilson Miller

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis